A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Clinical trial NCT07221149 · RECRUITING

Trial details

NCT number: NCT07221149
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Start date: 2026-03-13
Primary completion: 2030-11-08
Enrollment: 690

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.